Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 202

1.

High-Dose Citalopram and Escitalopram and the Risk of Out-of-Hospital Death.

Ray WA, Chung CP, Murray KT, Hall K, Stein CM.

J Clin Psychiatry. 2017 Feb;78(2):190-195. doi: 10.4088/JCP.15m10324.

PMID:
27736049
2.

Association of Proton Pump Inhibitors With Reduced Risk of Warfarin-Related Serious Upper Gastrointestinal Bleeding.

Ray WA, Chung CP, Murray KT, Smalley WE, Daugherty JR, Dupont WD, Stein CM.

Gastroenterology. 2016 Dec;151(6):1105-1112.e10. doi: 10.1053/j.gastro.2016.08.054. Epub 2016 Sep 14.

PMID:
27639805
3.

Prescription of Long-Acting Opioids and Mortality in Patients With Chronic Noncancer Pain.

Ray WA, Chung CP, Murray KT, Hall K, Stein CM.

JAMA. 2016 Jun 14;315(22):2415-23. doi: 10.1001/jama.2016.7789.

4.

Development of an algorithm to identify serious opioid toxicity in children.

Chung CP, Callahan ST, Cooper WO, Murray KT, Hall K, Dudley JA, Stein CM, Ray WA.

BMC Res Notes. 2015 Jul 4;8:293. doi: 10.1186/s13104-015-1185-x.

5.

Out-of-hospital mortality among patients receiving methadone for noncancer pain.

Ray WA, Chung CP, Murray KT, Cooper WO, Hall K, Stein CM.

JAMA Intern Med. 2015 Mar;175(3):420-7. doi: 10.1001/jamainternmed.2014.6294.

6.

Genotype and risk of major bleeding during warfarin treatment.

Kawai VK, Cunningham A, Vear SI, Van Driest SL, Oginni A, Xu H, Jiang M, Li C, Denny JC, Shaffer C, Bowton E, Gage BF, Ray WA, Roden DM, Stein CM.

Pharmacogenomics. 2014 Dec;15(16):1973-83. doi: 10.2217/pgs.14.153.

7.

Performance of time-dependent propensity scores: a pharmacoepidemiology case study.

Ray WA, Liu Q, Shepherd BE.

Pharmacoepidemiol Drug Saf. 2015 Jan;24(1):98-106. doi: 10.1002/pds.3727. Epub 2014 Nov 18.

8.

Azithromycin associated with a reduction in 90-day mortality among older pneumonia patients, although a true clinical benefit is uncertain.

Ray WA.

Evid Based Med. 2014 Dec;19(6):226-7. doi: 10.1136/ebmed-2014-110061. Epub 2014 Aug 13. No abstract available.

9.

Brief report: Risk of adverse fetal outcomes associated with immunosuppressive medications for chronic immune-mediated diseases in pregnancy.

Cooper WO, Cheetham TC, Li DK, Stein CM, Callahan ST, Morgan TM, Shintani AK, Chen N, Griffin MR, Ray WA.

Arthritis Rheumatol. 2014 Feb;66(2):444-50. doi: 10.1002/art.38262.

10.

Antidepressants and suicide attempts in children.

Cooper WO, Callahan ST, Shintani A, Fuchs DC, Shelton RC, Dudley JA, Graves AJ, Ray WA.

Pediatrics. 2014 Feb;133(2):204-10. doi: 10.1542/peds.2013-0923. Epub 2014 Jan 6.

11.

Antipsychotics and the risk of type 2 diabetes mellitus in children and youth.

Bobo WV, Cooper WO, Stein CM, Olfson M, Graham D, Daugherty J, Fuchs DC, Ray WA.

JAMA Psychiatry. 2013 Oct;70(10):1067-75. doi: 10.1001/jamapsychiatry.2013.2053.

PMID:
23965896
12.

Identifying suicidal behavior among adolescents using administrative claims data.

Callahan ST, Fuchs DC, Shelton RC, Balmer LS, Dudley JA, Gideon PS, Deranieri MM, Stratton SM, Williams CL, Ray WA, Cooper WO.

Pharmacoepidemiol Drug Saf. 2013 Jul;22(7):769-75. doi: 10.1002/pds.3421. Epub 2013 Feb 15.

13.

Propoxyphene and the risk of out-of-hospital death.

Ray WA, Murray KT, Kawai V, Graham DJ, Cooper WO, Hall K, Stein CM.

Pharmacoepidemiol Drug Saf. 2013 Apr;22(4):403-12. doi: 10.1002/pds.3411. Epub 2013 Feb 14.

14.

Validation of a computer case definition for sudden cardiac death in opioid users.

Kawai VK, Murray KT, Stein CM, Cooper WO, Graham DJ, Hall K, Ray WA.

BMC Res Notes. 2012 Aug 31;5:473. doi: 10.1186/1756-0500-5-473.

15.
16.

Adherence to transcranial Doppler screening guidelines among children with sickle cell disease.

Eckrich MJ, Wang WC, Yang E, Arbogast PG, Morrow A, Dudley JA, Ray WA, Cooper WO.

Pediatr Blood Cancer. 2013 Feb;60(2):270-4. doi: 10.1002/pbc.24240. Epub 2012 Jun 28.

PMID:
22744996
17.

Azithromycin and the risk of cardiovascular death.

Ray WA, Murray KT, Hall K, Arbogast PG, Stein CM.

N Engl J Med. 2012 May 17;366(20):1881-90. doi: 10.1056/NEJMoa1003833.

18.

ADHD medications and risk of serious cardiovascular events in young and middle-aged adults.

Habel LA, Cooper WO, Sox CM, Chan KA, Fireman BH, Arbogast PG, Cheetham TC, Quinn VP, Dublin S, Boudreau DM, Andrade SE, Pawloski PA, Raebel MA, Smith DH, Achacoso N, Uratsu C, Go AS, Sidney S, Nguyen-Huynh MN, Ray WA, Selby JV.

JAMA. 2011 Dec 28;306(24):2673-83. doi: 10.1001/jama.2011.1830. Epub 2011 Dec 12.

19.

Positive predictive value of automated database records for diabetic ketoacidosis (DKA) in children and youth exposed to antipsychotic drugs or control medications: a Tennessee Medicaid Study.

Bobo WV, Cooper WO, Epstein RA Jr, Arbogast PG, Mounsey J, Ray WA.

BMC Med Res Methodol. 2011 Nov 23;11:157. doi: 10.1186/1471-2288-11-157.

20.

ADHD drugs and serious cardiovascular events in children and young adults.

Cooper WO, Habel LA, Sox CM, Chan KA, Arbogast PG, Cheetham TC, Murray KT, Quinn VP, Stein CM, Callahan ST, Fireman BH, Fish FA, Kirshner HS, O'Duffy A, Connell FA, Ray WA.

N Engl J Med. 2011 Nov 17;365(20):1896-904. doi: 10.1056/NEJMoa1110212. Epub 2011 Nov 1.

Supplemental Content

Support Center